GI & Endoscopy

Although study results show RedHill Biopharma's irritable bowel syndrome with diarrhea drug Bekinda, improves stool consistency compared to a placebo, investors sent the drugmaker's stock tumbling because of poor secondary endpoint results, Reuters reports.

Steven Desautels, MD, is a gastroenterologist at Sandy, Utah-based Granite Peaks Gastroenterology.

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Sept. 25 to Sept. 29, 2017.

Here are 15 updates on GI companies from September:

Molham Abdulsamad, MD, joined the staff of Lewistown, Pa.-based Geisinger Gastroenterology and Endoscopy Center, The Sentinel reports.

A study, published in Digestive Diseases and Sciences, analyzed the efficacy of Medial EarlySign's ColonFlag.

The American Association of Medical Assistants is joining the effort to increase colorectal cancer screenings rates.

A study, published in the Journal of Clinical Gastroenterology, examined why patients missed appointments at an outpatient gastroenterology clinic.

Benigno Varela, MD, is a gastroenterologist at Hamden-based Gastroenterology Center of Connecticut.

Pittsfield, Mass.-based Berkshire Medical Center is moving its endoscopy unit from Pittsfield-based Crane Center for Ambulatory Surgery into the main hospital, The Berkshire Eagle reports.